5/9
11:09 am
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
High
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $18.00 price target on the stock.
5/9
11:07 am
npce
Rating for NPCE
High
Report
Rating for NPCE